0001492422 2026-02-20 2026-02-20 0001492422 1 2026-02-20 2026-02-20 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0001492422 Apellis Pharmaceuticals, Inc. N/A false S-8 Apellis Pharmaceuticals, Inc. Equity Common Stock, $0.0001 par value per share true 4719409 21.62 102033622.58 0.0001381 14090.84 102033622.58 14090.84 0.00 14090.84 (1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. (2) Consists of (i) 4,219,409 additional shares issuable under the 2017 Stock Incentive Plan and (ii) 500,000 additional shares issuable under the 2017 Employee Stock Purchase Plan. (3) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Registrant's Common Stock as reported on the Nasdaq Global Select Market on February 17, 2026.